Health
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers – GlobeNewswire
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required…
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers
- First-in-class drug blocks key signals required for tumour growth and metastasis
- Highly targeted so avoids damaging healthy cells potential for improved patient outcomes
- Modulus Oncology is currently in discussions for seed and series A investment
Sheffield, UK, 9 September 2020: Modulus Oncology, a new and rapidly emerging private biotech company focused on tr…
Continue Reading
-
General20 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News23 hours agoTips to improve engagement – Proctor
-
Noosa News23 hours agoPolice appeal for information over suspected link in torture and murder cases
-
Noosa News17 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says